Kala
Kala is a behavioral intelligence platform for patient adherence, personalizing interventions around the psychological drivers of non-adherence.
Problem & solution
Many patients don't adhere to treatment, often driven by fear, unreported side-effect toxicity, or cognitive burden rather than simple forgetfulness. Kala is a condition-agnostic behavioral intelligence platform that identifies these psychological drivers of non-adherence and delivers personalized interventions to keep patients on treatment.
Primary customers & users
Health systems, specialty pharmacies, and pharmaceutical/biotech companies seeking to improve patient adherence; the platform connects patients, caregivers, and healthcare providers.
Differentiation
Condition-agnostic by design, targeting the underlying psychological drivers of non-adherence (fear, unreported toxicity, cognitive burden) rather than a single disease or medication category.
Current traction
Pre-seed stage with a working interactive demo live, plus proposal-stage conversations with a mid-sized U.S. health system and a specialty-pharmacy channel partner.
How Summit participants can help
We're looking for our first design partners and pilot opportunities — health systems, specialty pharmacies, and pharma/biotech teams open to testing Kala with real patients. Beyond that, connections across the US healthcare industry — operators, channel partners, and investors as we plan our funding round, plus time with fellow Israeli founders to trade lessons on breaking into the market.